GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » RYAH Group Inc (XCNQ:RYAH) » Definitions » Current Accrued Expense

RYAH Group (XCNQ:RYAH) Current Accrued Expense : C$0.00 Mil (As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is RYAH Group Current Accrued Expense?

RYAH Group's Current Accrued Expense for the quarter that ended in Sep. 2022 was C$0.00 Mil.

RYAH Group's annual Current Accrued Expense increased from . 20 (C$0.00 Mil) to Dec. 2020 (C$0.12 Mil) but then declined from Dec. 2020 (C$0.12 Mil) to Dec. 2021 (C$0.00 Mil).


RYAH Group Current Accrued Expense Historical Data

The historical data trend for RYAH Group's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RYAH Group Current Accrued Expense Chart

RYAH Group Annual Data
Trend Dec20 Dec21
Current Accrued Expense
0.12 -

RYAH Group Quarterly Data
Feb20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Current Accrued Expense Get a 7-Day Free Trial - - - - -

RYAH Group Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


RYAH Group Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of RYAH Group's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


RYAH Group (XCNQ:RYAH) Business Description

Traded in Other Exchanges
N/A
Address
68 34TH STREET, SUITE B421, BROOKLYN, NY, USA, 11232
RYAH Group Inc is a data technology company in plant-based medicine. Its Artificial Intelligence platform aggregates and correlates HIPAA-compliant dosing data from seed to consumption. This helps the company to conduct predictive analyses to help doctors, researchers, and end-users create personalized dosing regimens that can accurately foresee patient outcomes. the company also provide other products which are smart inhaler system & smart patch system.

RYAH Group (XCNQ:RYAH) Headlines

No Headlines